|
2014 Chronic Hep C: Treat Now or Wait?
(Preview)
Here is a slide presentation that may help provide those making this decision, treat now or wait. Hepatitis C: Treat Now or Wait?
|
Tig
|
3
|
889
|
|
|
|
|
Daclatasvir/Olysio Combo Effectively Treats Hep C Genotype 1b
(Preview)
Daclatasvir/Olysio Combo Effectively Treats Hep C Genotype 1b A combination of low-dose daclatasvir and Olysio (simeprevir) cured a relatively high proportion of people with genotype 1b of hepatitis C virus (HCV), but just two thirds of a small group of genotype 1as. Findings from the LEAGUE-...
|
Tig
|
2
|
1213
|
|
|
|
|
HCV and HIV Vaccine Research
(Preview)
http://www.healio.com/hepatology/chronic-hepatitis/news/online/%7Ba80b5165-93ef-4373-8c39-ec11541cb833%7D/hcv-hiv-vaccine-research-focuses-on-indirect-dendritic-cell-stimulation
|
Tig
|
0
|
722
|
|
|
|
|
Infectious Disease News Updates
(Preview)
Here are some updates that I think you all might find interesting. The first in the group deals with patient adherence. One of the biggest causes of premature treatment failure was due to the pill burden. The new treatments are so much better in that respect. When I was on treatment recently, taking th...
|
Tig
|
1
|
956
|
|
|
|
|
European Medicines Agency Validates Gilead's Marketing Application for Ledipasvir/Sofosbuvir
(Preview)
"...Although accelerated assessment of this investigational fixed-dose combination could shorten EMA's review time by approximately two months, it does not guarantee a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) or final approval by the Europe...
|
OldenSlow
|
2
|
929
|
|
|
|
|
Gilead offers Egypt new hepatitis C drug at 99 pct discount
(Preview)
(Reuters) - "Gilead Sciences, facing mounting criticism over the high price of its new hepatitis C pill Sovaldi, has offered to supply the medicine to Egypt at a 99 percent discount to the U.S. price. While the drug will still cost $900 for a 12-week course of treatment, that is a fraction of...
|
OldenSlow
|
8
|
1398
|
|
|
|
|
Sovaldi/Olysio Survey Data
(Preview)
From the Decision Resources Group March 19, 2014 "Cost is the leading prescribing barrier for both Olysio and Sovaldi. Although most surveyed prescribers did not indicate major payer obstacles, many non-prescribers reported experiencing reimbursement obstacles, suggesting that re...
|
OldenSlow
|
3
|
1483
|
|
|
|
|
Hep C Guide: FORWARD MOTION
(Preview)
I found this easy to read guide released by drug maker Abbvie. Might help some people understand this better. I like to say, "Knowledge is Power"! HCV: FORWARD MOTION Tig
|
Tig
|
0
|
1078
|
|
|
|
|
New hepatitis C drugs must be affordable worldwide
(Preview)
"We are witnessing a revolution in the treatment of hepatitis C virus with powerful molecules capable of curing the infection. There is no question that these treatments that can save millions of lives must be made universally available at an affordable price." - Francoise Barre-Si...
|
OldenSlow
|
0
|
826
|
|
|
|
|
NY Times article re Solvaldi costs
(Preview)
NY Times article: NY Times: How much should HCV treatment cost? -- Edited by Tig56 on Monday 17th of March 2014 04:11:42 AM
|
JIme
|
2
|
1313
|
|
|
|
|
Conversations from CROI 2014: Dr. Douglas Dieterich on Important Advances in Hepatitis C
(Preview)
Embedded video worth a look.. http://blog.aids.gov/2014/03/conversations-from-croi-2014-dr-douglas-dieterich-on-important-advances-in-hepatitis-c.html
|
OldenSlow
|
4
|
927
|
|
|
|
|
SOVALDI: Product Monograph
(Preview)
I decided to post an easy to find PDF description of this newest drug by Gilead Sciences. This will assist those searching the forum database as well as boosting it's search engine position via the forum. http://www.gilead.ca/pdf/ca/sovaldi_pm_english.pdf Tig
|
Tig
|
2
|
1352
|
|
|
|
|
New Treatment Options for Hepatitis C in 2014
(Preview)
Web presentation by Columbia University Medical Center. 40 minutes long and clinical in nature, but up to date. Recorded on 2/27/14. Q&A at the end. http://hepatitiscnewdrugs.blogspot.com/2014/03/new-treatment-options-for-hepatitis-c.html
|
OldenSlow
|
1
|
1273
|
|
|
|
|
Abbvie Findings: 2014 Conference on Retroviruses and Opportunistic Infections
(Preview)
http://www.healio.com/infectious-disease/croi-2014-resource-center/ribavirin-unnecessary-addition-to-3-drug-combination-for-hcv-treatment
|
Tig
|
2
|
1004
|
|
|
|
|
More on the Medicare/Medicaid Problem
(Preview)
From Bloomberg.com March 4, 2014... "The new drug has arrived as the 2010 Patient Protection and Affordable Care Act, known as Obamacare, promises to add more than 12 million people to the Medicaid program in a nationwide expansion. At the same time, health-care costs for states continue to...
|
OldenSlow
|
2
|
970
|
|
|
|
|
March 2014 HCV Advocate Newsletter
(Preview)
March 2014 HCV Newsletter, from the HCV Advocate website. Articles included this month... - Gilead files for FDA Approval of Sofosbuvir (Sovaldi)/Ledipasvir combo - Hep C and Nutrition - Co-Pay Assistance - Disability and Benefits: Completing Questionnaires - HCV Drug Development News[url]h...
|
Cinnamon Girl
|
0
|
766
|
|
|
|
|
Abbvie Reveals New DAA Resistance Profiles WOW the race is heating up
(Preview)
Hello All Today Abbvie released there resistance profiles on not only their new DAA's in the pipeline (ABT-530 and ABT-493) but also about their current drugs (ABT-450 and ABT-267) Very interesting on all RAVs that can be produced with the older DAA's Follow these links to read the data and graphs h...
|
Matt Chris
|
0
|
896
|
|
|
|
|
Brief Overview of HCV Drug Data (DAA`s) Released at CROI 2014
(Preview)
Tuesday, March 4, 2014 - CROI (Conference on Retroviruses and Opportunistic Infections) is an annual conference that focuses on research information about HIV. In the last few years, more and more coverage has been presented on HCV monoinfection and HIV/HCV coinfection. The table below is a br...
|
Cinnamon Girl
|
0
|
827
|
|
|
|
|
FDA Approves Gilead’s Sovaldi (Sofosbuvir)
(
1 2
)
(Preview)
Dec. 6, 2013 - The US FDA has approved Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.Sovaldi`s efficacy has been established in...
|
Cinnamon Girl
|
84
|
7853
|
|
|
|
|
Pharma Refuses to Ensure Equitable Access to HCV treatment at Global Meeting
(Preview)
Bangkok, Thailand, February 28, 2014 - Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies....
|
Cinnamon Girl
|
3
|
953
|
|
|
|
|
New DAA's and the Medicaid Budget Problem
(Preview)
From USA TODAY March 3, 2014:"State Medicaid agencies are just now beginning to react to the implications of the two new medicines. The majority of Medicaid beneficiaries are in managed care plans, but those managed care plans set their capitation rates (the amount Medicaid pays managed car...
|
OldenSlow
|
0
|
910
|
|
|
|
|
Photo of My $28,000.00 Worth of Sovaldi Pills & Bottle
(Preview)
Most people won't be able to afford this, even with insurance. My co-pay this month for JUST 28 Sovaldi pills was $5,556.70. It should go down next month, but I need 6 months of treatment. I wonder WHY there are only 28 pills/bottle instead of 30, when the treatment is always for a specific number of mon...
|
Mila
|
11
|
2212
|
|
|
|
|
Costly hepatitis drug Sovaldi rattles industry
(Preview)
From the Washington Post.. http://www.washingtonpost.com/national/health-science/costly-hepatitis-drug-sovaldi-rattles-industry/2014/03/01/86cab0b4-a091-11e3-9ba6-800d1192d08b_story.html
|
OldenSlow
|
0
|
797
|
|
|
|
|
New Slideshow on Hep C new drugs. Worth watching
(Preview)
Wait?http://hepatitiscnewdrugs.blogspot.com/2014/03/an-update-treat-hepatitis-c-now-or-wait.htmlThe-- Edited by suziq on Saturday 1st of March 2014 04:2...
|
suziq
|
6
|
1234
|
|
|
|
|
NATAP ~ Hepatitis C Select Articles
(Preview)
Take a moment to bookmark these pages. They include a wealth of recent and updated articles on several pertinent topics. http://www.natap.org/hcv.htm http://www.natap.org/pageone.htm Tig
|
Tig
|
1
|
963
|
|
|
|
|
Clarifying the Release date of Sofosbuvir and Ledipasvir
(Preview)
Hey all Wanted to clarify the possible time line for Sofosbuvir & Ledipasvir to be available to Patients. After reading the FDA web site about how NDA (New Drug Applications) are processed I was somewhat confused on the timing issue. The Standard review time is 10 months but the Priority review t...
|
Matt Chris
|
0
|
1018
|
|
|
|
|
HCV News updates
(Preview)
I came across this website that offers a number of current reports on issues directly and indirectly related to present therapies being offered. I think you'll find several interesting articles discussing the topics we've been discussing here recently. http://www.healio.com/infectious-di...
|
Tig
|
0
|
962
|
|
|
|
|
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C
(Preview)
Great News for the future Demise of HCV Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C Follow this linkhttp://hepatitiscnewdrugs.blogspot.com/2014/02/gilead-files-for-us-approvalledipasvirs.html
|
Matt Chris
|
21
|
3633
|
|
|
|
|
BMS Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Regimen
(Preview)
Monday, February 24, 2014 PRINCETON, N.J. - Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational DCV Dual Regimen (daclatasvir and asunaprevir) Breakthrough Therapy Designation for use as a combination therapy in the...
|
Cinnamon Girl
|
0
|
807
|
|
|
|
|
Eurpean Medicines Agency advises on compassionate use of ledipasvir/sofosbuvir combo
(Preview)
Press release, 21/02/2014 - Combination of ledipasvir and sofosbuvir to be used in patients in urgent need of therapy to prevent progression of liver disease.`The European Medicines Agency`s Committee for Medicinal Products for Human Use (CHMP) has given an opinion on the use of a fixed-dose com...
|
Cinnamon Girl
|
3
|
1014
|
|
|
